A detailed history of First Horizon Corp transactions in Uni Qure N.V. stock. As of the latest transaction made, First Horizon Corp holds 386 shares of QURE stock, worth $24,673. This represents 0.0% of its overall portfolio holdings.

Number of Shares
386
Previous 102 278.43%
Holding current value
$24,673
Previous $3,000 633.33%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 24, 2025

BUY
$13.28 - $59.4 $3,771 - $16,869
284 Added 278.43%
386 $22,000
Q1 2021

May 11, 2021

BUY
$29.24 - $42.03 $2,982 - $4,287
102 New
102 $3,000

Others Institutions Holding QURE

About uniQure N.V.


  • Ticker QURE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,729,100
  • Market Cap $2.99B
  • Description
  • uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...
More about QURE
Track This Portfolio

Track First Horizon Corp Portfolio

Follow First Horizon Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Horizon Corp, based on Form 13F filings with the SEC.

News

Stay updated on First Horizon Corp with notifications on news.